The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Globally, liver cancer and head and neck cancers are more prevalent in Singapore and Asia. Read more at straitstimes.com.

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

Hepatitis B surface antigen (HBsAg) seroclearance is recommended as the ideal endpoint for nucleos(t)ide analog (NA) treatments. Functional cure of chronic hepatitis B (CHB) is defined as having ...

Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...

In 2023, three Northern Ontario health unit areas that make up two per cent of the provincial population accounted for 10 per ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

David C. Hastings, the Chief Financial Officer of Arbutus Biopharma Corp (NASDAQ:ABUS), recently sold 22,183 common shares of ...

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its ...